An open-label, multi-center randomized, phase 3 study of ibrutinib combined with
obinutuzumab versus Chlorambucil in combination with obinutuzumab in subjects with
treatment-naïve Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
AKH Linz, Linz, Austria; Recruiting
Michael Fridrik, M.D, Principal Investigator
LKH - Universitätsklinikum der PMU Salzburg, Salzburg, Austria; Recruiting
Richard Greil, M.D, Principal Investigator
ZNA Stuivenberg, Antwerpen, Belgium; Recruiting
Ka Lung Wu, M.D, Principal Investigator
Institut Jules Bordet, Bruxelles, Belgium; Recruiting
Dominique Bron, M.D, Principal Investigator
Grand Hôpital de Charleroi, Charleroi, Belgium; Recruiting
Julien Depaus, MD, Principal Investigator
UZ Leuven, Leuven, Belgium; Recruiting
Ann Janssens, M.D, Principal Investigator
AZ Turnhout - Campus Sint-Elisabeth, Turnhout, Belgium; Recruiting
Inge Vrelust, M.D, Principal Investigator
Fakultni nemocnice Hradec Kralove, Hradec Kralove, Czech Republic; Recruiting
Lukas Smolej, M.D, Principal Investigator
Fakultni nemocnice Kralovske Vinohrady, Praha 10, Czech Republic; Recruiting
Jan Novak, M.D, Principal Investigator
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna, Italy; Recruiting
Pier Luigi Zinzani, M.D, Principal Investigator
Azienda Ospedaliera Universitaria Careggi, Firenze, Italy; Recruiting
Alberto Bosi, M.D, Principal Investigator
Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milano, Italy; Recruiting
Alessandra Tedeschi, M.D, Principal Investigator
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; Recruiting
Agostino Cortellezi, M.D, Principal Investigator
Ospedale San Raffaele, Milano, Italy; Recruiting
Paolo Ghia, M.D, Principal Investigator
A.O.U. Policlinico di Modena, Modena, Italy; Recruiting
Roberto Marasca, M.D, Principal Investigator
Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy; Recruiting
Gianluca Gaidano, M.D, Principal Investigator
Policlinico Universitario Agostino Gemelli, Roma, Italy; Recruiting
Luca Laurenti, M.D, Principal Investigator
A.O.U. Senese Policlinico Santa Maria alle Scotte, Siena, Italy; Recruiting
Monica Bocchia, M.D, Principal Investigator
North Shore Hospital, Auckland, New Zealand; Recruiting
David Simpson, M.D, Principal Investigator
Waikato Hospital, Hamilton, New Zealand; Recruiting
Shahdul Islam, M.D, Principal Investigator
Hospital Clinic i Provincial de Barcelona, Barcelona, Spain; Recruiting
Julio Delgado, M.D, Principal Investigator
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Recruiting
Carolina Moreno Atanasio, M.D, Principal Investigator
Hospital Universitari Vall d'Hebron, Barcelona, Spain; Recruiting
Francesc Bosch Albareda, M.D, Principal Investigator
Hospital Universitario 12 de Octubre, Madrid, Spain; Recruiting
Javier de la Serna Torroba, M.D, Principal Investigator
START Madrid. Centro Integral Oncologico Clara Campal, Madrid, Spain; Recruiting
Jaime Perez de Oteyza, M.D, Principal Investigator
Södra Älvsborgs Sjukhus, Borås, Borås, Sweden; Recruiting
Per-ola Andersson, M.D, Principal Investigator
Sunderby sjukhus, Luleå, Sweden; Recruiting
Birgitta Lauri, M.D, Principal Investigator
Skånes Universitetssjukhus, Lund, Lund, Sweden; Recruiting
Karin Karlsson, M.D, Principal Investigator
Karolinska, Stockholm, Sweden; Recruiting
Anders Osterborg, M.D, Principal Investigator
Ankara University Medical Faculty, Ankara, Turkey; Recruiting
Onder Arslan, M.D, Principal Investigator
Gazi University Medical Faculty, Ankara, Turkey; Recruiting
Munci Yagci, M.D, Principal Investigator
Pamukkale Uni. Med. Fac., Denizli, Turkey; Recruiting
Hakan Ismail Sari, M.D, Principal Investigator
Dokuz Eylul University Medicine Faculty, Izmir, Turkey; Recruiting
Fatih Demirkan, M.D, Principal Investigator
Erciyes University Medical Faculty, Kayseri, Turkey; Recruiting
Leylagul Kaynar, M.D, Principal Investigator
Ondokuz Mayis Univ. Med. Fac., Samsun, Turkey; Recruiting
Duzgun Ozatli, M.D, Principal Investigator
University of Alberta Hospital, Edmonton, Alberta, Canada; Recruiting
Loree Larratt, M.D, Principal Investigator
University of San Diego Medical Center, La Jolla, California, United States; Recruiting
Thomas Kipps, M.D, Principal Investigator
Princess Alexandra Hospital, Harlow, Essex, United Kingdom; Recruiting
Faris Al-Refaie, M.D, Principal Investigator
Florida Cancer Specialists - Broadway, Fort Myers, Florida, United States; Recruiting
Scott Lunin, M.D, Principal Investigator
Florida Cancer Specialists, West Palm Beach, Florida, United States; Recruiting
Robert Jacobson, M.D, Principal Investigator
IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy; Recruiting
Nicola Cascavilla, M.D, Principal Investigator
Groupe Hospitalier Sud - Hôpital Haut-Lévêque - Centre François Magendie, Pessac cedex, Gironde, France; Recruiting
Marie-Sarah Dilhuydy, M.D, Principal Investigator
Norton Cancer Institute, Louisville, Kentucky, United States; Recruiting
Don Stevens, M.D, Principal Investigator
CHU Nantes - Hôtel Dieu, Nantes cedex 1, Loire Atlantique, France; Recruiting
Beatrice Mahe, M.D, Principal Investigator
ICO l´Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat, Madrid, Spain; Recruiting
Eva Gonzalez Barca, M.D, Principal Investigator
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain; Recruiting
Jose Antonio Garcia Marco, M.D, Principal Investigator
Hôpital de Brabois Adultes, Vandoeuvre les Nancy, Meurthe et Moselle, France; Recruiting
Pierre Feugier, M.D, Principal Investigator
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States; Recruiting
Edwin Kingsley, M.D, Principal Investigator
Westmead Hospital, Westmead, New South Wales, Australia; Recruiting
David Gottlieb, M.D, Principal Investigator
Southeastern Medical Oncology Center, Goldsboro, North Carolina, United States; Recruiting
James Atkins, M.D, Principal Investigator
Oncology Hematology Care, Inc, Cincinnati, Ohio, United States; Recruiting
James Essell, M.D, Principal Investigator
Centre Hospitalier de la côte Basque, Bayonne, Pyrenees Atlantiques, France; Recruiting
Carla Araujo, M.D, Principal Investigator
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia; Recruiting
Devinder Gill, M.D, Principal Investigator
Centre Hospitalier Lyon Sud, Pierre Bénite, Rhone, France; Recruiting
Anne-Sophie Michallet, M.D, Principal Investigator
Royal Adelaide Hospital, Adelaide, South Australia, Australia; Recruiting
Luen Bik To, M.D, Principal Investigator
Royal Hobart Hospital, Hobart, Tasmania, Australia; Recruiting
Rosemary Harrup, M.D, Principal Investigator
Tennessee Oncology, PLLC, Chattanooga, Tennessee, United States; Recruiting
Bertrand Anz, M.D, Principal Investigator
Tennesse Oncology, Nashville, Tennessee, United States; Recruiting
Ian Flinn, M.D, Principal Investigator
Ballarat Base Hospital, Ballarat, Victoria, Australia; Recruiting
Geoffrey Chong, M.D, Principal Investigator
Box Hill Hospital, Box Hill, Victoria, Australia; Recruiting
Paul Coughlin, M.D, Principal Investigator
St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia; Recruiting
Mohammad Bazargan, M.D, Principal Investigator
Austin Hospital, Heidelberg, Victoria, Australia; Recruiting
Paul Turner, M.D, Principal Investigator
St James's Institute of Oncology, Leeds, West Yorkshire, United Kingdom; Recruiting
Peter Hillmen, M.D, Principal Investigator